SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosi s who wrote (1185)8/27/1998 12:38:00 AM
From: Ariella   of 1491
 
Yosi, thanks for that legwork about the milestone payment. Thought I'd post something for perspective. Another drug company working on traumatic brain injury and other CNS problems was briefly mentioned in the Wall Street Journal Interactive Edition today. CNSI is the stock. Today they announced a major preclinical advance in treatment for MS and the stock shot up 30%.

But, oh, did I mention that a year ago they were selling for $5 a share and now trade for 69 cents a share, including today's runup? They lost a major collaborator last year and fired half their staff and stayed alive. Thank goodness our downward drift is not so huge. But their chart rather gives a sobering perspective to ours.

By the way, we must make the message clear to PARS management that really professional PR work is an absolute MUST if we get a favorable HU-211 report. CNSI issued a strongly worded release and got its 30% rise today even though the work for the drug is in preclinical phase. It already has an analyst following it so that it gets recorded in Zack's estimates.

PARS is still not on the map anywhere and WE SHOULD BE!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext